Kheterpal Meenal, Mehta-Shah Neha, Virmani Pooja, Myskowski Patricia L, Moskowitz Alison, Horwitz Steven M
Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center, 500 Westchester Ave, West Harrison, NY, 10604, USA.
Curr Hematol Malig Rep. 2016 Jun;11(3):224-33. doi: 10.1007/s11899-016-0322-5.
Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.
皮肤淋巴瘤（CL）是一组异质性肿瘤，其特征在于临床和组织病理学变异，以及与良性皮肤病的重叠。CL的诊断和治疗具有挑战性，通常需要多学科方法。然而，对这些疾病的预后了解以及对治疗选择的认识有助于优化现有方案的合理使用，从而改善患者护理。在此，我们综述了最新文献，并概述了除蕈样肉芽肿外的皮肤B细胞和T细胞淋巴瘤患者的治疗主题。
